Form 8-K - Current report:
SEC Accession No. 0000950170-23-009847
Filing Date
2023-03-27
Accepted
2023-03-27 07:00:48
Documents
42
Period of Report
2023-03-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ubx-20230327.htm   iXBRL 8-K 60086
2 EX-99.1 ubx-ex99_1.htm EX-99 48333
3 EX-99.2 ubx-ex99_2.htm EX-99 20912
4 GRAPHIC img240635130_0.jpg GRAPHIC 6628
5 GRAPHIC ubx-ex99_2s1.jpg GRAPHIC 311573
6 GRAPHIC ubx-ex99_2s2.jpg GRAPHIC 655007
7 GRAPHIC ubx-ex99_2s3.jpg GRAPHIC 479114
8 GRAPHIC ubx-ex99_2s4.jpg GRAPHIC 435039
9 GRAPHIC ubx-ex99_2s5.jpg GRAPHIC 455913
10 GRAPHIC ubx-ex99_2s6.jpg GRAPHIC 473801
11 GRAPHIC ubx-ex99_2s7.jpg GRAPHIC 398790
12 GRAPHIC ubx-ex99_2s8.jpg GRAPHIC 302131
13 GRAPHIC ubx-ex99_2s9.jpg GRAPHIC 256035
14 GRAPHIC ubx-ex99_2s10.jpg GRAPHIC 465635
15 GRAPHIC ubx-ex99_2s11.jpg GRAPHIC 301105
16 GRAPHIC ubx-ex99_2s12.jpg GRAPHIC 320771
17 GRAPHIC ubx-ex99_2s13.jpg GRAPHIC 417022
18 GRAPHIC ubx-ex99_2s14.jpg GRAPHIC 279135
19 GRAPHIC ubx-ex99_2s15.jpg GRAPHIC 269182
20 GRAPHIC ubx-ex99_2s16.jpg GRAPHIC 311911
21 GRAPHIC ubx-ex99_2s17.jpg GRAPHIC 298204
22 GRAPHIC ubx-ex99_2s18.jpg GRAPHIC 310456
23 GRAPHIC ubx-ex99_2s19.jpg GRAPHIC 293890
24 GRAPHIC ubx-ex99_2s20.jpg GRAPHIC 344950
25 GRAPHIC ubx-ex99_2s21.jpg GRAPHIC 308462
26 GRAPHIC ubx-ex99_2s22.jpg GRAPHIC 347846
27 GRAPHIC ubx-ex99_2s23.jpg GRAPHIC 403700
28 GRAPHIC ubx-ex99_2s24.jpg GRAPHIC 522039
29 GRAPHIC ubx-ex99_2s25.jpg GRAPHIC 372064
30 GRAPHIC ubx-ex99_2s26.jpg GRAPHIC 540949
31 GRAPHIC ubx-ex99_2s27.jpg GRAPHIC 262356
  Complete submission text file 0000950170-23-009847.txt   14231113

Data Files

Seq Description Document Type Size
32 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ubx-20230327_pre.xml EX-101.PRE 9851
33 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ubx-20230327_lab.xml EX-101.LAB 13350
34 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ubx-20230327.xsd EX-101.SCH 2484
36 EXTRACTED XBRL INSTANCE DOCUMENT ubx-20230327_htm.xml XML 4715
Mailing Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-1192
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

EIN.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38470 | Film No.: 23761417
SIC: 2834 Pharmaceutical Preparations